Baidu
map

免开刀切除肠道肿瘤的新装置:熊掌

2015-06-11 卧月眠海 煎蛋网

这个能够切除早期肠道肿瘤的绰号叫“熊掌”,全称为“全层切除装置”的新发明,被誉为是预防肠道癌的重大突破。“熊掌”有点像鳄鱼夹,使用时只要夹住病变组织,并将“熊掌”上端的“帽子”往上提就可以了。之前曾有过类似于“熊掌”的设备,但是只能切除很薄的一片组织,并没有多少实用价值。有些病人不得不通过复杂的大手术来移除肠道肿瘤,因为这些肿瘤在没有得到及时治疗的情况下,将有十分之一的几率发展成癌症。而在英国,每

这个能够切除早期肠道肿瘤的绰号叫“熊掌”,全称为“全层切除装置”的新发明,被誉为是预防肠道癌的重大突破。“熊掌”有点像鳄鱼夹,使用时只要夹住病变组织,并将“熊掌”上端的“帽子”往上提就可以了。之前曾有过类似于“熊掌”的设备,但是只能切除很薄的一片组织,并没有多少实用价值。

有些病人不得不通过复杂的大手术来移除肠道肿瘤,因为这些肿瘤在没有得到及时治疗的情况下,将有十分之一的几率发展成癌症。而在英国,每年都有40,000被检查出患有肠道癌,百分之九十以上还是六十岁以上的老年人,他们中的四分之一需要动手术。


手术可以只移除表层细胞,但那样患者依然有患癌的风险,但若切除太多的组织则会使患者有肠道壁撕裂的风险,甚至会导致危及生命的严重感染。非手术去除肿瘤的方法有:用连接着软管的细小针头将其切除,或是用激光之类的将肿瘤内细胞烫死。但若是肿瘤长在肠道壁深处的话,这些都不是一个很好的选择。


而在英国南安普顿总医院,一位医生率先使用了“熊掌”解决了一个棘手的病例,他仅用了45分钟就将病变组织完全切除了。手术过程中不需要手术刀,肠穿孔的风险也大大降低了。由于肠道壁没有疼痛神经,在做完手术后,病人也可以很快就出院。南安普顿医院胃肠病学顾问Philip Boger告诉我们:这个发明具有里程碑的意义,许多患者将不必接受一个大手术。而至今为止,Boger医生已经在三名患者身上使用了“熊掌”。



退休护工Gwen Smith是接受“熊掌”手术的人,若她的肿瘤不切除,现在很可能就已经演变为癌症,并且癌细胞也可能已扩散到身体各个部位。Smith曾经面临着两个选择:高风险的常规腹部手术,并需要带上一个气孔袋,或是在南安普顿接受“熊掌”手术。Smith说:“当我得知我拥有一个避免大手术的选择时,我非常高兴。我是一个健康并且活跃的老人,当我一想到要在医院住上几天,并可能有一个气孔袋,我就十分不爽。手术进行地十分迅速,当我被麻醉时是9:15,45分钟后一切就都结束了,而在12:45时我就已经到家了。”

Boger医生补充说:“我们很多病人都是上了年纪的老年人,他们进行手术时会有更大的风险。对于Smith夫人来说,我们完全能够使用‘熊掌’来避免一场大手术,将病人的不适程度和手术风险度降到最低,并让他们能够尽快恢复。”

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
    2015-07-08 dwtouxx

    厉害

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
    2015-07-05 Gsurgeon

    新技术

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
    2015-06-29 owlhealth

    这么牛

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
    2015-06-25 huaxipanxing

    看看

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
    2015-06-15 huangsong808

    现代科技的力量!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
    2015-06-12 da1215225

    有前途

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
    2015-06-11 Darcy2500

    有前途

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1756426, encodeId=5ab41e56426b9, content=<a href='/topic/show?id=ade081e29da' target=_blank style='color:#2F92EE;'>#肠道肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81729, encryptionId=ade081e29da, topicName=肠道肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51bd37139333, createdName=chshh89, createdTime=Thu Feb 18 05:44:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31590, encodeId=75ef315905d, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 08 12:16:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30806, encodeId=921a30806a7, content=新技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jul 05 16:12:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29944, encodeId=d6ef2994406, content=这么牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 19:01:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29422, encodeId=2e1e29422f7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:49:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27684, encodeId=80e72e6842b, content=现代科技的力量!, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d031628224, createdName=huangsong808, createdTime=Mon Jun 15 18:56:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27310, encodeId=74fa2e3109e, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:38:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27225, encodeId=501e2e22557, content=有前途, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c31627260, createdName=Darcy2500, createdTime=Thu Jun 11 23:45:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27169, encodeId=826d2e1693d, content=科技的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Thu Jun 11 21:07:00 CST 2015, time=2015-06-11, status=1, ipAttribution=)]
    2015-06-11 18619c0a62m

    科技的力量

    0

相关资讯

JCI:辣椒可预防肠道肿瘤

北京时间8月5日消息,科学日报报道,美国加州大学圣地亚哥分校的研究人员报告称饮食辣椒素——辣椒里的活跃成分——会导致老鼠肠细胞皮层受体的慢性激活,从而引发一种反应,这种反应可减少大肠肿瘤的风险。这项发现被发表在8月1日的期刊《临床研究》上。名为TRPV1的受体或者离子通道最初发现于感官神经元,它作为抵抗环境里热量、酸性和辣的化学物质的守卫。“这都是对细胞潜在有害的刺激物。” 研究高级作者、医学教授

Baidu
map
Baidu
map
Baidu
map